IMDX
Insight Molecular Diagnostics Inc.
4.00$
+1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +80.8% | -56.4% | +56.9% | +25.1% | +115.6% | |
| – | – | +36.7% | +49.9% | -3.6% | -38.5% | +439.2% | -58.1% | +25.4% | +11.7% | +4.7% | +238.7% | |
| – | – | – | – | – | – | – | – | -101.3% | – | +79.2% | -74.3% | |
| – | +14.3% | +25.4% | +26.4% | -9.2% | +4.3% | +44.2% | -48.6% | +45.0% | +27.3% | +5.9% | +61.6% | |
| – | +314.5% | +30.4% | +69.0% | -24.1% | +89.5% | +26.4% | +21.4% | +5.5% | -39.7% | +1.3% | -19.1% | |
| – | +75.3% | +27.8% | +69.2% | -19.3% | +46.3% | +30.7% | +89.7% | -67.4% | +42.1% | +141.8% | -50.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +850.0% | +47.4% | +675.0% | -0.5% | +38.4% | -15.7% | -17.1% | -60.3% | -37.3% | +61.5% | +29.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -254.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.